Reverse convertibles – What are the risks for Investors?
Reverse convertibles are short-term structured products that combine a debt instrument with an embedded derivative—a short put option on a reference asset—and are typically sold by broker-dealers and financial advisors to retail investors seeking yields above what traditional bonds offer. They are issued by major investment banks such as Barclays, J.P. Morgan, Goldman Sachs, Citi, Morgan Stanley, and UBS, and marketed under various names including reverse convertible notes, equity-linked securities, and yield optimization notes. Each note pays a fixed, above-market coupon—often 7–20% annualized—for a short maturity period, usually three months to one year. In exchange for that coupon, the investor effectively writes a put option on a reference asset, most commonly an individual stock. If the stock falls below a predetermined knock-in barrier, typically set at 70–80% of its starting price, the investor’s principal is converted into shares of the depreciated stock at maturity.
Continue Reading